• OPEN AN ACCOUNT
Indian Indices
Nifty
26,013.45 103.40
(0.40%)
Sensex
84,950.95 388.17
( 0.46%)
Bank Nifty
58,962.70 445.15
( 0.76%)
Nifty IT
36,375.20 73.95
( 0.20%)
Global Indices
Nasdaq
47,163.83 -314.39
(-0.66%)
Dow Jones
6,754.35 -4.14
(-0.06%)
Hang Seng
50,246.57 -129.96
(-0.26%)
Nikkei 225
9,695.49 -2.88
(-0.03%)
Forex
USD-INR
88.71 0.12
(0.13%)
EUR-INR
103.04 0.44
(0.43%)
GBP-INR
116.72 0.41
(0.35%)
JPY-INR
0.57 0.00
(0.16%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
100.5174369
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
44.35
41977.12
EPS(TTM)
Face Value()
Div & Yield %
55.87
10
2.18
 

As on: Nov 17, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,491.15 13.25 5851 44.35
Stock Price Details
Open Price() 2,554.15
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,554.15
Today's Low () 2,475.00
52-Week High () 3515.95
152-Week Low () 1924.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.18
Eps 55.87
Book Value 100.5174369
Market Cap (.Cr) 41,977.12
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
Indices tumble in early trade; breadth weak
Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Investor Presentation
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals schedules board meeting
Glaxosmithkline Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Trading Window
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi